466-480 of 878
Updates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
ASH Action CenterUpdates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
Charles Turck, PharmD, BCPS, BCCCP
Clifford Takemoto, MD
Updates in SCD: Posters from the 64th ASH Annual Meeting
ASH Action CenterUpdates in SCD: Posters from the 64th ASH Annual Meeting
Bridging the Gaps in Care: Key Posters from the 64th Annual ASH Meeting
ASH Action CenterBridging the Gaps in Care: Key Posters from the 64th Annual ASH Meeting
A Look at Representation in Hematologic Clinical Trials
ASH Action CenterA Look at Representation in Hematologic Clinical Trials
Charles Turck, PharmD, BCPS, BCCCP
Namrata Chandhok, MD
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Project Oncology®Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Pavani Chalasani, MD, MPH
Hope S. Rugo, MD, FASCO
Recognizing the Role of Capmatinib for METex14 in NSCLC
Project Oncology®Recognizing the Role of Capmatinib for METex14 in NSCLC
Jacob Sands, MD
Edward B. Garon, MD, MS
- advertisement
Diving into the Genetic Pathway: A Look at the STING Pathway & Brain Cancer
NeuroFrontiersDiving into the Genetic Pathway: A Look at the STING Pathway & Brain Cancer
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Sean Lawler, PhD
Considering CAR T-cell Therapy in Follicular Lymphoma
Medical Breakthroughs from Penn MedicineConsidering CAR T-cell Therapy in Follicular Lymphoma
Charles Turck, PharmD, BCPS, BCCCP
Elise Chong, MD
Exploring New Research on Melanoma Brain Metastases
NeuroFrontiersExploring New Research on Melanoma Brain Metastases
Benjamin Izar, MD
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Project Oncology®Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Pavani Chalasani, MD, MPH
Prof. David Cameron
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Project Oncology®Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Pavani Chalasani, MD, MPH
Erika Hamilton, MD
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Project Oncology®Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Pavani Chalasani, MD, MPH
Kevin Kalinsky MD, MS
- advertisement
Highlights from ASCO 2022: A Look at Key Poster Sessions & Emerging Clinical Data
Project Oncology®Highlights from ASCO 2022: A Look at Key Poster Sessions & Emerging Clinical Data
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Project Oncology®The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Pavani Chalasani, MD, MPH
Nan Chen, MD
Treating Metastatic Breast Cancer: Where Are We Now?
Project Oncology®Treating Metastatic Breast Cancer: Where Are We Now?
Pavani Chalasani, MD, MPH
Seema A. Khan, MD
